annual operating profit:
-$2.54M+$101.17M(+97.55%)Summary
- As of today (May 29, 2025), BCRX annual operating income is -$2.54 million, with the most recent change of +$101.17 million (+97.55%) on December 31, 2024.
- During the last 3 years, BCRX annual operating profit has risen by +$175.18 million (+98.57%).
- BCRX annual operating profit is now at all-time high.
Performance
BCRX Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
$21.23M+$25.73M(+570.87%)Summary
- As of today (May 29, 2025), BCRX quarterly operating income is $21.23 million, with the most recent change of +$25.73 million (+570.87%) on March 31, 2025.
- Over the past year, BCRX quarterly operating profit has increased by +$35.72 million (+246.51%).
- BCRX quarterly operating profit is now at all-time high.
Performance
BCRX quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
$33.17M+$35.72M(+1404.44%)Summary
- As of today (May 29, 2025), BCRX TTM operating income is $33.17 million, with the most recent change of +$35.72 million (+1404.44%) on March 31, 2025.
- Over the past year, BCRX TTM operating profit has increased by +$122.95 million (+136.95%).
- BCRX TTM operating profit is now at all-time high.
Performance
BCRX TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
BCRX Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +97.5% | +246.5% | +136.9% |
| 3 y3 years | +98.6% | +142.5% | +118.8% |
| 5 y5 years | +97.4% | +151.8% | +129.9% |
BCRX Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +98.6% | at high | +142.5% | at high | +118.3% |
| 5 y | 5-year | at high | +98.6% | at high | +140.5% | at high | +117.9% |
| alltime | all time | at high | +98.6% | at high | +140.5% | at high | +117.9% |
BCRX Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $21.23M(-570.9%) | $33.17M(-1404.4%) |
| Dec 2024 | -$2.54M(-97.5%) | -$4.51M(-158.6%) | -$2.54M(-93.8%) |
| Sep 2024 | - | $7.69M(-12.2%) | -$40.70M(-32.5%) |
| Jun 2024 | - | $8.76M(-160.5%) | -$60.32M(-32.8%) |
| Mar 2024 | - | -$14.49M(-66.0%) | -$89.78M(-13.4%) |
| Dec 2023 | -$103.71M(-30.1%) | -$42.67M(+257.9%) | -$103.71M(-3.4%) |
| Sep 2023 | - | -$11.92M(-42.4%) | -$107.35M(-4.9%) |
| Jun 2023 | - | -$20.70M(-27.1%) | -$112.87M(-11.0%) |
| Mar 2023 | - | -$28.41M(-38.6%) | -$126.89M(-14.5%) |
| Dec 2022 | -$148.44M(-16.5%) | -$46.31M(+165.5%) | -$148.44M(-3.8%) |
| Sep 2022 | - | -$17.45M(-49.8%) | -$154.30M(-15.0%) |
| Jun 2022 | - | -$34.72M(-30.5%) | -$181.44M(+2.9%) |
| Mar 2022 | - | -$49.96M(-4.3%) | -$176.30M(-0.8%) |
| Dec 2021 | -$177.72M(+1.7%) | -$52.18M(+17.0%) | -$177.72M(-0.1%) |
| Sep 2021 | - | -$44.58M(+50.7%) | -$177.95M(+1.0%) |
| Jun 2021 | - | -$29.58M(-42.4%) | -$176.23M(-4.8%) |
| Mar 2021 | - | -$51.38M(-2.0%) | -$185.16M(+6.0%) |
| Dec 2020 | -$174.76M(+75.7%) | -$52.41M(+22.3%) | -$174.76M(+42.7%) |
| Sep 2020 | - | -$42.86M(+11.3%) | -$122.46M(+6.8%) |
| Jun 2020 | - | -$38.51M(-6.0%) | -$114.69M(+3.2%) |
| Mar 2020 | - | -$40.98M(>+9900.0%) | -$111.10M(+11.7%) |
| Dec 2019 | -$99.45M(+5.6%) | -$109.00K(-99.7%) | -$99.45M(-20.2%) |
| Sep 2019 | - | -$35.10M(+0.5%) | -$124.61M(+5.6%) |
| Jun 2019 | - | -$34.92M(+19.1%) | -$118.00M(+16.4%) |
| Mar 2019 | - | -$29.33M(+16.1%) | -$101.34M(+7.6%) |
| Dec 2018 | -$94.22M(+64.1%) | -$25.26M(-11.3%) | -$94.22M(+8.5%) |
| Sep 2018 | - | -$28.49M(+56.1%) | -$86.82M(+21.1%) |
| Jun 2018 | - | -$18.25M(-17.8%) | -$71.67M(+4.0%) |
| Mar 2018 | - | -$22.21M(+24.4%) | -$68.94M(+20.1%) |
| Dec 2017 | -$57.41M(+18.1%) | -$17.86M(+33.8%) | -$57.41M(+20.3%) |
| Sep 2017 | - | -$13.35M(-14.0%) | -$47.74M(+9.4%) |
| Jun 2017 | - | -$15.52M(+45.2%) | -$43.63M(+8.4%) |
| Mar 2017 | - | -$10.69M(+30.5%) | -$40.24M(-17.2%) |
| Dec 2016 | -$48.61M(+23.2%) | -$8.19M(-11.4%) | -$48.61M(-15.6%) |
| Sep 2016 | - | -$9.24M(-23.8%) | -$57.61M(-6.4%) |
| Jun 2016 | - | -$12.13M(-36.3%) | -$61.53M(+39.7%) |
| Mar 2016 | - | -$19.05M(+10.8%) | -$44.06M(+11.7%) |
| Dec 2015 | -$39.44M(-13.8%) | -$17.19M(+30.6%) | -$39.44M(+5.4%) |
| Sep 2015 | - | -$13.16M(-346.4%) | -$37.41M(+4.3%) |
| Jun 2015 | - | $5.34M(-137.0%) | -$35.85M(-32.1%) |
| Mar 2015 | - | -$14.43M(-4.8%) | -$52.81M(+15.4%) |
| Dec 2014 | -$45.77M(+49.0%) | -$15.16M(+30.5%) | -$45.77M(+23.9%) |
| Sep 2014 | - | -$11.61M(-0.1%) | -$36.95M(+14.5%) |
| Jun 2014 | - | -$11.62M(+57.3%) | -$32.26M(-1.6%) |
| Mar 2014 | - | -$7.39M(+16.6%) | -$32.79M(+6.7%) |
| Dec 2013 | -$30.72M(-4.4%) | -$6.33M(-8.5%) | -$30.72M(-7.8%) |
| Sep 2013 | - | -$6.92M(-43.0%) | -$33.32M(-3.2%) |
| Jun 2013 | - | -$12.14M(+128.4%) | -$34.41M(+6.1%) |
| Mar 2013 | - | -$5.32M(-40.5%) | -$32.44M(+1.0%) |
| Dec 2012 | -$32.13M(-35.2%) | -$8.94M(+11.5%) | -$32.13M(-6.2%) |
| Sep 2012 | - | -$8.02M(-21.2%) | -$34.23M(-12.3%) |
| Jun 2012 | - | -$10.18M(+103.5%) | -$39.02M(-9.4%) |
| Mar 2012 | - | -$5.00M(-54.7%) | -$43.09M(-13.1%) |
| Dec 2011 | -$49.59M(+48.8%) | -$11.04M(-13.8%) | -$49.59M(+3.7%) |
| Sep 2011 | - | -$12.80M(-10.1%) | -$47.82M(+3.9%) |
| Jun 2011 | - | -$14.24M(+23.9%) | -$46.01M(+9.3%) |
| Mar 2011 | - | -$11.50M(+24.0%) | -$42.09M(+26.3%) |
| Dec 2010 | -$33.32M(+142.6%) | -$9.27M(-15.6%) | -$33.32M(+271.8%) |
| Sep 2010 | - | -$10.99M(+6.4%) | -$8.96M(+3.4%) |
| Jun 2010 | - | -$10.33M(+278.5%) | -$8.67M(+22.5%) |
| Mar 2010 | - | -$2.73M(-118.1%) | -$7.08M(-48.5%) |
| Dec 2009 | -$13.74M | $15.09M(-241.0%) | -$13.74M(-27.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$10.70M(+22.4%) | -$19.02M(+6.3%) |
| Jun 2009 | - | -$8.74M(-6.9%) | -$17.89M(-20.6%) |
| Mar 2009 | - | -$9.39M(-195.7%) | -$22.54M(-17.0%) |
| Dec 2008 | -$27.16M(-15.8%) | $9.80M(-202.4%) | -$27.16M(-32.8%) |
| Sep 2008 | - | -$9.57M(-28.5%) | -$40.40M(-5.4%) |
| Jun 2008 | - | -$13.38M(-4.5%) | -$42.69M(+15.7%) |
| Mar 2008 | - | -$14.02M(+308.9%) | -$36.89M(+54.9%) |
| Dec 2007 | -$32.28M(-31.3%) | -$3.43M(-71.1%) | -$23.81M(-23.5%) |
| Sep 2007 | - | -$11.86M(+56.4%) | -$31.12M(-12.9%) |
| Jun 2007 | - | -$7.58M(+705.9%) | -$35.72M(-8.8%) |
| Mar 2007 | - | -$940.80K(-91.2%) | -$39.15M(-16.7%) |
| Dec 2006 | -$46.98M(+72.9%) | -$10.74M(-34.8%) | -$46.98M(+7.4%) |
| Sep 2006 | - | -$16.46M(+49.4%) | -$43.73M(+24.2%) |
| Jun 2006 | - | -$11.02M(+25.7%) | -$35.20M(+16.9%) |
| Mar 2006 | - | -$8.77M(+17.1%) | -$30.11M(+10.8%) |
| Dec 2005 | -$27.18M(+24.9%) | -$7.49M(-5.5%) | -$27.18M(+8.2%) |
| Sep 2005 | - | -$7.93M(+33.6%) | -$25.12M(+10.9%) |
| Jun 2005 | - | -$5.93M(+1.7%) | -$22.64M(+3.2%) |
| Mar 2005 | - | -$5.83M(+7.4%) | -$21.94M(+0.9%) |
| Dec 2004 | -$21.75M(+59.0%) | -$5.43M(-0.4%) | -$21.75M(+5.8%) |
| Sep 2004 | - | -$5.45M(+4.2%) | -$20.55M(+11.0%) |
| Jun 2004 | - | -$5.23M(-7.3%) | -$18.51M(+12.0%) |
| Mar 2004 | - | -$5.64M(+33.4%) | -$16.53M(+20.9%) |
| Dec 2003 | -$13.68M(-26.9%) | -$4.23M(+24.1%) | -$13.68M(-4.6%) |
| Sep 2003 | - | -$3.41M(+4.8%) | -$14.33M(-0.0%) |
| Jun 2003 | - | -$3.25M(+16.6%) | -$14.34M(-12.2%) |
| Mar 2003 | - | -$2.79M(-42.9%) | -$16.34M(-14.8%) |
| Dec 2002 | -$18.70M(+275.2%) | -$4.88M(+43.0%) | -$19.16M(+13.5%) |
| Sep 2002 | - | -$3.42M(-34.9%) | -$16.88M(+24.3%) |
| Jun 2002 | - | -$5.25M(-6.6%) | -$13.59M(+64.0%) |
| Mar 2002 | - | -$5.62M(+115.6%) | -$8.28M(+58.3%) |
| Dec 2001 | -$4.99M(-49.3%) | -$2.60M(+2088.7%) | -$5.23M(-7.9%) |
| Sep 2001 | - | -$119.00K(-316.4%) | -$5.68M(-24.7%) |
| Jun 2001 | - | $55.00K(-102.1%) | -$7.55M(-24.8%) |
| Mar 2001 | - | -$2.57M(-16.0%) | -$10.04M(+1.6%) |
| Dec 2000 | -$9.83M(+21.4%) | -$3.06M(+54.0%) | -$9.88M(+7.1%) |
| Sep 2000 | - | -$1.98M(-18.5%) | -$9.23M(-6.2%) |
| Jun 2000 | - | -$2.43M(+0.9%) | -$9.85M(+24.3%) |
| Mar 2000 | - | -$2.41M(+0.5%) | -$7.92M(-1.1%) |
| Dec 1999 | -$8.10M(+35.0%) | -$2.40M(-7.7%) | -$8.01M(+8.1%) |
| Sep 1999 | - | -$2.60M(+411.6%) | -$7.41M(+207.6%) |
| Jun 1999 | - | -$508.00K(-79.7%) | -$2.41M(-52.8%) |
| Mar 1999 | - | -$2.50M(+38.9%) | -$5.10M(-12.1%) |
| Dec 1998 | -$6.00M(-51.2%) | -$1.80M(-175.0%) | -$5.80M(-21.6%) |
| Sep 1998 | - | $2.40M(-175.0%) | -$7.40M(-41.3%) |
| Jun 1998 | - | -$3.20M(0.0%) | -$12.60M(+5.9%) |
| Mar 1998 | - | -$3.20M(-5.9%) | -$11.90M(-2.5%) |
| Dec 1997 | -$12.30M(+41.4%) | -$3.40M(+21.4%) | -$12.20M(+1.7%) |
| Sep 1997 | - | -$2.80M(+12.0%) | -$12.00M(+3.4%) |
| Jun 1997 | - | -$2.50M(-28.6%) | -$11.60M(+11.5%) |
| Mar 1997 | - | -$3.50M(+9.4%) | -$10.40M(+18.2%) |
| Dec 1996 | -$8.70M(-4.4%) | -$3.20M(+33.3%) | -$8.80M(+11.4%) |
| Sep 1996 | - | -$2.40M(+84.6%) | -$7.90M(+3.9%) |
| Jun 1996 | - | -$1.30M(-31.6%) | -$7.60M(-5.0%) |
| Mar 1996 | - | -$1.90M(-17.4%) | -$8.00M(-11.1%) |
| Dec 1995 | -$9.10M(+33.8%) | -$2.30M(+9.5%) | -$9.00M(+4.7%) |
| Sep 1995 | - | -$2.10M(+23.5%) | -$8.60M(+4.9%) |
| Jun 1995 | - | -$1.70M(-41.4%) | -$8.20M(-2.4%) |
| Mar 1995 | - | -$2.90M(+52.6%) | -$8.40M(+20.0%) |
| Dec 1994 | -$6.80M | -$1.90M(+11.8%) | -$7.00M(+37.3%) |
| Sep 1994 | - | -$1.70M(-10.5%) | -$5.10M(+50.0%) |
| Jun 1994 | - | -$1.90M(+26.7%) | -$3.40M(+126.7%) |
| Mar 1994 | - | -$1.50M | -$1.50M |
FAQ
- What is BioCryst Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual operating profit year-on-year change?
- What is BioCryst Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly operating profit year-on-year change?
- What is BioCryst Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM operating profit year-on-year change?
What is BioCryst Pharmaceuticals annual operating income?
The current annual operating profit of BCRX is -$2.54M
What is the all time high annual operating profit for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual operating income is -$2.54M
What is BioCryst Pharmaceuticals annual operating profit year-on-year change?
Over the past year, BCRX annual operating income has changed by +$101.17M (+97.55%)
What is BioCryst Pharmaceuticals quarterly operating income?
The current quarterly operating profit of BCRX is $21.23M
What is the all time high quarterly operating profit for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly operating income is $21.23M
What is BioCryst Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, BCRX quarterly operating income has changed by +$35.72M (+246.51%)
What is BioCryst Pharmaceuticals TTM operating income?
The current TTM operating profit of BCRX is $33.17M
What is the all time high TTM operating profit for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM operating income is $33.17M
What is BioCryst Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, BCRX TTM operating income has changed by +$122.95M (+136.95%)